Today, the Vector Institute announced the renewal of its collaboration with Roche through 2030, extending a connection that ...
FS Vector, a leading Washington, D.C.-based strategic consulting firm for companies innovating in financial services, today ...
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced a 30-minute oral presentation on TG4050, the ...
Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 March 27, 2026 8:30 ...
Full-year results and business updateTransgene Continues Progressto Reshape Early-Stage Cancer Treatmentthrough Individualized Neoantigen ...
Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap”), a global leader in Non-Lethal Response (“NLR”) technologies and public ...
The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...
New National Forecast Signals Expanding Vector-Borne Disease Risk for Dogs -- with Implications for Human Health and a 94%+ Accurate Early Warning System SALEM, Ore., March 23, 2026 /PRNewswire/ -- ...
Nadofaragene firadenovec-vncg is the only FDA-approved nonreplicating intravesical gene therapy for high-risk ...
Legal observers warn that FinCEN retains broad authority over real estate transactions — and could ultimately impose stricter ...
Open-source is nice, but that’s not the interesting part here.
For a few hours each lunar day, the radiation environment near the moon quietly shifts. Measurements now suggest that parts ...